Question Title

* 1. How old was your loved one when they were diagnosed with epilepsy?

Question Title

* 2. How much longer, after an epilepsy diagnosis, did it take to get a CDKL5 Deficiency Disorder (CDD) diagnosis?

Question Title

* 3. Was this confirmed through a genetic test?

Question Title

* 4. How effective have current treatments been in managing your loved one’s seizures?

Question Title

* 5. How easy or difficult has it been to access CDKL5 Deficiency Disorder (CDD)-specialists?

Question Title

* 6. What sources do you rely on most for information about CDKL5 Deficiency Disorder (CDD) treatments? (Rank 1 being most important, 5 being least important)

Question Title

* 7. What do you feel is the biggest unmet need in your loved one’s current CDKL5 Deficiency Disorder (CDD) treatment plan?

Question Title

* 8. What factors are most important to you when considering a new treatment option for your loved one?

Question Title

* 9. How challenging is it for you to coordinate care across healthcare providers, services, and support systems for your loved one?

Question Title

* 10. Which caregiver or family support needs related to CDKL5 Deficiency Disorder (CDD) need the most improvement? (Select TOP 3)

Question Title

* 11. How valuable would caregiver-focused support programs provided by a pharmaceutical company be in improving your family’s ability to manage CDKL5 Deficiency Disorder (CDD)?

Question Title

* 12. Which member of your loved one’s healthcare team do you trust most to support your family’s needs related to CDKL5 Deficiency Disorder (CDD)?

Question Title

* 13. Are there areas in which you feel your loved one’s’s healthcare team does not adequately support you or your family?

T